Skip to content

Cocoa Polyphenols and Postprandial Metabolism in Type 2 Diabetes

Postprandial Effects of Polyphenol-rich Cocoa Beverage on Glucose, Insulin, Lipids, Oxidative Stress and Inflammation in Type 2 Diabetic Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01886989
Enrollment
18
Registered
2013-06-26
Start date
2012-01-31
Completion date
2014-12-31
Last updated
2018-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

diabetes, cocoa polyphenols, postprandial glycemia, postprandial lipemia

Brief summary

This study aims to investigate the postprandial effects of cocoa supplementation in glucose and lipids, and surrogate markers of atherosclerosis in patients with type 2 diabetes. The investigators aim to test the hypothesis that cocoa will lower high-fat mixed meal breakfast-induced postprandial rise of glucose, lipids and markers of atherosclerosis in patients with diabetes. Randomized cross-over controlled trial, in which participants will be assigned to the placebo or cocoa group with breakfast meal. Patients with type 2 diabetes(n=25) will qualify for the study. The participants will be asked to consume 2 cups cocoa or placebo beverage on 2 separate postprandial study days. Both groups will receive high-fat mixed meal breakfast on each day. Blood draws and blood pressure (including HDI) measurements will be conducted at fasting, 30 min, 1,2, 4 & 6 hours postprandial each day for 2 days.

Interventions

DIETARY_SUPPLEMENTCocoa polyphenols

Cocoa polyphenols (960mg) reconstituted in water

Sponsors

Arpita Basu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* clinical diagnosis of type 2diabetes

Exclusion criteria

* on insulin therapy

Design outcomes

Primary

MeasureTime frameDescription
Blood pressure (mm Hg)2.5 yearsChange in blood pressure and vascular function following cocoa and placebo intervention

Secondary

MeasureTime frameDescription
Glucose (mg/dL)2.5 yearsChange in glucose levels at fasting, 30min, 1, 2, 4, & 6 hours postprandial following cocoa and placebo intervention
Blood lipids2.5 yearsChange in lipids and lipoprotein levels at fasting, 30min, 1, 2, 4, & 6 hours postprandial following cocoa
Inflammation2.5 yearsChange in CRP and interleukins levels at fasting, 30min, 1, 2, 4, & 6 hours postprandial following cocoa

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026